Genenta Science S.p.A.
GNTA
$2.30
$0.010.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.17M | -2.01M | -2.60M | -2.68M | -2.17M |
| Total Depreciation and Amortization | 7.90K | 7.30K | 11.90K | 12.30K | 11.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 303.30K | 281.30K | 344.20K | 355.00K | 142.30K |
| Change in Net Operating Assets | -1.27M | -1.18M | 12.60K | 13.00K | 911.50K |
| Cash from Operations | -3.13M | -2.90M | -2.23M | -2.30M | -1.11M |
| Capital Expenditure | -4.30K | -4.00K | -1.40K | -1.40K | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.51M | -2.33M | 1.38M | 1.42M | 2.32M |
| Cash from Investing | -2.52M | -2.33M | 1.38M | 1.42M | 2.31M |
| Total Debt Issued | 3.75M | 3.75M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.49M | 1.49M | 0.00 | 0.00 | 135.40K |
| Cash from Financing | 5.95M | 5.51M | 0.00 | 0.00 | 145.80K |
| Foreign Exchange rate Adjustments | 39.50K | 36.70K | -3.90K | -4.00K | -8.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 337.60K | 313.00K | -856.10K | -882.90K | 1.34M |